Bruce Lavin

Bruce Lavin serves as Adjunct Professor of Biomedical Science at Georgia State University's Institute for Biomedical Sciences and Vice President, Head of External Engagement and Policy and Medical Affairs in UCB Pharma's Neurology Division, while maintaining active clinical practice in Internal Medicine, Infectious Diseases, and Critical Care.

Education:

• Doctor of Medicine (MD) from Uniformed Services University of the Health Sciences
• Master of Public Health (MPH) in Health Policy and Administration from UCLA School of Public Health and Business Administration
• First-year law studies at American University, Western College of Law

Research Interests: His work integrates Neurology drug development with clinical Infectious Diseases and Critical Care practice, informed by expertise in Health Policy and Public Health administration. This cross-disciplinary focus bridges pharmaceutical industry leadership, academic medicine, and patient care systems.

Professional Affiliations: Current board positions include Georgia Tech, Morehouse College, Cobb County Chamber of Commerce, and AMSUS (Association of Military Surgeons of the US). Prior to UCB (joined 2013), he held executive medical roles at Sanofi-Aventis, Novartis, and Bristol-Myers Squibb, with clinical faculty appointments at University of California, San Francisco and Davis.